Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein
- 1 September 2001
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 29 (9) , 1082-1090
- https://doi.org/10.1016/s0301-472x(01)00688-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemiaJournal of Clinical Investigation, 2000
- Characterization of the Interleukin-1β-Converting Enzyme/Ced-3-Family Protease, Caspase-3/CPP32, in Hodgkin's DiseaseThe American Journal of Pathology, 1999
- Inhibitors of tyrosine kinaseCurrent Opinion in Oncology, 1997
- ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)Oncogene, 1997
- Herbimycin A Induces the 20 S Proteasome- and Ubiquitin-dependent Degradation of Receptor Tyrosine KinasesJournal of Biological Chemistry, 1995
- Detection of NPM‐ALK DNA rearrangement in CD30 positive anaplastic large cell lymphomaBritish Journal of Haematology, 1995
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994
- New Insight into Oncoprotein-Targeted Antitumor Effect: Herbimycin a as an Antagonist of Protein Tyrosine Kinase against Ph1-Positive Leukemia CellsLeukemia & Lymphoma, 1993
- Major nucleolar proteins shuttle between nucleus and cytoplasmCell, 1989
- A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (‘Ki‐1 lymphoma')British Journal of Haematology, 1989